1. Home
  2. AIRG vs XBIT Comparison

AIRG vs XBIT Comparison

Compare AIRG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

N/A

Current Price

$3.96

Market Cap

52.7M

Sector

Technology

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.95

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRG
XBIT
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
57.6M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
AIRG
XBIT
Price
$3.96
$1.95
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $6.88
N/A
AVG Volume (30 Days)
57.0K
★ 82.6K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.65
N/A
EPS
★ N/A
N/A
Revenue
★ $51,779,000.00
N/A
Revenue This Year
$10.21
N/A
Revenue Next Year
$15.26
$30.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.63
$1.80
52 Week High
$7.66
$2.73

Technical Indicators

Market Signals
Indicator
AIRG
XBIT
Relative Strength Index (RSI) 41.60 45.36
Support Level $3.83 $1.83
Resistance Level $5.65 $2.42
Average True Range (ATR) 0.22 0.11
MACD 0.00 0.01
Stochastic Oscillator 38.36 45.45

Price Performance

Historical Comparison
AIRG
XBIT

About AIRG Airgain Inc.

Airgain Incs a provider of advance wireless connectivity solutions. It is focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. It mission is to connect the world through integrated, and optimized wireless solutions. Companies' diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While historically recognized for high-performance radio frequency (RF) components, Airgain is increasingly delivering integrated, system-level connectivity solutions that combine hardware, software, and cloud management. The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings suburbs.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: